We narrowed to 8,660 results for: gal

#213856-PHPeB

Ready-to-use AAV PHP.eB particles produced from pAAV_BiVIPe4_ChR2_mCherry (#213856). In addition to the viral particles, you will also receive purified pAAV_BiVIPe4_ChR2_mCherry plasmid DNA. Expression of mCherry-tagged channelrhodopsin-2 under the control of the VIP interneuron-targeting enhancer E4. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.

Gordon Fishell

Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1

Dec. 2, 2024

Academic Institutions and Nonprofits only

#213829-PHPeB

Ready-to-use AAV PHP.eB particles produced from pAAV_BiCHATe27_dTomato_nlsdTomato (#213829). In addition to the viral particles, you will also receive purified pAAV_BiCHATe27_dTomato_nlsdTomato plasmid DNA. Bicistronic expression of dTomato and nuclear-targeted dTomato under the control of the cholinergic neuron-targeting enhancer E27. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.

Gordon Fishell

Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1

Dec. 2, 2024

Academic Institutions and Nonprofits only

#213937-PHPeB

Ready-to-use AAV PHP.eB particles produced from pAAV_BiPVe4_ChR2_mCherry (#213937). In addition to the viral particles, you will also receive purified pAAV_BiPVe4_ChR2_mCherry plasmid DNA. Expression of mCherry-tagged channelrhodopsin-2 under the control of the chandelier cell-targeting enhancer E4. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.

Gordon Fishell

Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1

Dec. 2, 2024

Academic Institutions and Nonprofits only

#213915-PHPeB

Ready-to-use AAV PHP.eB particles produced from pAAV_BiLAMP5e3_ChR2_mCherry (#213915). In addition to the viral particles, you will also receive purified pAAV_BiLAMP5e3_ChR2_mCherry plasmid DNA. Expression of mCherry-tagged channelrhodopsin-2 under the control of the Lamp5 interneuron-targeting enhancer E3. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.

Gordon Fishell

Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1

Dec. 2, 2024

Academic Institutions and Nonprofits only

#213818-PHPeB

Ready-to-use AAV PHP.eB particles produced from pAAV_BiSSTe10_GCaMP6f (#213818). In addition to the viral particles, you will also receive purified pAAV_BiSSTe10_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the SST interneuron-targeting enhancer E10. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.

Gordon Fishell

Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1

Sept. 23, 2025

Academic Institutions and Nonprofits only

#221463-PHPeB

Ready-to-use AAV PHP.eB particles produced from pAAV_BiPVe4_eGFP (#221463). In addition to the viral particles, you will also receive purified pAAV_BiPVe4_eGFP plasmid DNA. Expression of EGFP under the control of the chandelier cell-targeting enhancer E4. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.

Gordon Fishell

Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1

Sept. 23, 2025

Academic Institutions and Nonprofits only

#1000000005

Can be used to efficiently assemble zinc finger arrays via modular assembly (Sangamo, Barbas, and Toolgen). Also includes the bacterial two-hybrid (B2H) system used to screen arrays for activity.

Keith Joung

July 16, 2011

Academic Institutions and Nonprofits only

#102259

ompF deletion strain for overproduction of outer membrane proteins

Jack Leo

Meuskens et al Front Cell Infect Microbiol. 2017 Nov 7;

Nov. 10, 2017

Academic Institutions and Nonprofits only

#102256

ompA deletion strain for overproduction of outer membrane proteins

Jack Leo

Meuskens et al Front Cell Infect Microbiol. 2017 Nov 7;

Nov. 10, 2017

Academic Institutions and Nonprofits only

#102258

ompC deletion strain for overproduction of outer membrane proteins

Jack Leo

Meuskens et al Front Cell Infect Microbiol. 2017 Nov 7;

Nov. 10, 2017

Academic Institutions and Nonprofits only

#102257

lamB deletion strain for overproduction of outer membrane proteins

Jack Leo

Meuskens et al Front Cell Infect Microbiol. 2017 Nov 7;

Nov. 10, 2017

Academic Institutions and Nonprofits only

#102263

lamB, ompC double knockout strain for overproduction of outer membrane proteins

Jack Leo

Meuskens et al Front Cell Infect Microbiol. 2017 Nov 7;

Nov. 10, 2017

Academic Institutions and Nonprofits only

#102269

lamB, ompC, ompF triple knockout strain for overproduction of outer membrane proteins

Jack Leo

Meuskens et al Front Cell Infect Microbiol. 2017 Nov 7;

Nov. 14, 2017

Academic Institutions and Nonprofits only

#102265

ompC, ompF double knockout strain for overproduction of outer membrane proteins

Jack Leo

Meuskens et al Front Cell Infect Microbiol. 2017 Nov 7;

Nov. 10, 2017

Academic Institutions and Nonprofits only

#102268

ompA, ompC, ompF triple knockout strain for overproduction of outer membrane proteins

Jack Leo

Meuskens et al Front Cell Infect Microbiol. 2017 Nov 7;

Nov. 14, 2017

Academic Institutions and Nonprofits only

#102266

ompA, lamB, ompC triple knockout strain for overproduction of outer membrane proteins

Jack Leo

Meuskens et al Front Cell Infect Microbiol. 2017 Nov 7;

Nov. 10, 2017

Academic Institutions and Nonprofits only

#102261

ompA, ompC double knockout strain for overproduction of outer membrane proteins

Jack Leo

Meuskens et al Front Cell Infect Microbiol. 2017 Nov 7;

Nov. 10, 2017

Academic Institutions and Nonprofits only

#102262

ompA, ompF double knockout strain for overproduction of outer membrane proteins

Jack Leo

Meuskens et al Front Cell Infect Microbiol. 2017 Nov 7;

Nov. 10, 2017

Academic Institutions and Nonprofits only

#102267

ompA, lamB, ompF triple knockout strain for overproduction of outer membrane proteins

Jack Leo

Meuskens et al Front Cell Infect Microbiol. 2017 Nov 7;

Nov. 10, 2017

Academic Institutions and Nonprofits only

#102264

lamB, ompF double knockout strain for overproduction of outer membrane proteins

Jack Leo

Meuskens et al Front Cell Infect Microbiol. 2017 Nov 7;

Nov. 10, 2017

Academic Institutions and Nonprofits only

#102260

ompA, lamB double knockout strain for overproduction of outer membrane proteins

Jack Leo

Meuskens et al Front Cell Infect Microbiol. 2017 Nov 7;

Nov. 10, 2017

Academic Institutions and Nonprofits only

#67755

a derivative of E. coli strain NCM3722 which has been cured of the F plasmid

Suckjoon Jun

Brown et al Genome Announc. 2015 Aug 6;3(4). pii: e0

Aug. 20, 2015

Academic Institutions and Nonprofits only

#235121

E. coli strain suitable for cloning, expression, library construction (good electroporation yield) and quantitative bacterial two-hybrid (qB2H).

Oscar Ramos

Oct. 27, 2025

Academic Institutions and Nonprofits only

#1000000012

190 human kinases and kinase-related open reading frames (ORFs) cloned into a retroviral vector which adds a myristoylation sequence and flag-epitope tag to each ORF.

William Hahn

July 16, 2011

Academic Institutions and Nonprofits only

#102270

ompA, lamB, ompC, ompF quadruple knockout strain for overproduction of outer membrane proteins

Jack Leo

Meuskens et al Front Cell Infect Microbiol. 2017 Nov 7;

Nov. 10, 2017

Academic Institutions and Nonprofits only

#218768

E. coli strain, genotype: EcNR1 pUltraG ScW40 CCA trpS::ZeoR trpT::gentR dgalK lambdaRED::galK

Abhishek Chatterjee

Italia et al Nat Chem Biol. 2017 Apr;13(4):446-450. d

June 21, 2024

Academic Institutions and Nonprofits only

#48936

Base line strain is heat shock induce-able lambda red recombination system for MAGE (Multiplex Recombination Genome Engineering)

George Church

Dec. 3, 2014

Academic Institutions and Nonprofits only

#48937

Base line strain is heat shock induce-able lambda red recombination system for MAGE (Multiplex Recombination Genome Engineering)

George Church

Dec. 3, 2014

Academic Institutions and Nonprofits only

#48930

diversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.

George Church

Dec. 3, 2014

Academic Institutions and Nonprofits only

#48931

diversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.

George Church

Dec. 3, 2014

Academic Institutions and Nonprofits only

#48932

diversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.

George Church

Dec. 3, 2014

Academic Institutions and Nonprofits only

#48933

diversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.

George Church

Dec. 3, 2014

Academic Institutions and Nonprofits only

#48934

diversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.

George Church

Dec. 3, 2014

Academic Institutions and Nonprofits only

#48921

diversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.

George Church

Dec. 3, 2014

Academic Institutions and Nonprofits only

#48922

diversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.

George Church

Dec. 3, 2014

Academic Institutions and Nonprofits only

#48923

diversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.

George Church

Dec. 3, 2014

Academic Institutions and Nonprofits only

#48924

diversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.

George Church

Dec. 3, 2014

Academic Institutions and Nonprofits only

#48925

diversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.

George Church

Dec. 3, 2014

Academic Institutions and Nonprofits only

#48926

diversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.

George Church

Dec. 3, 2014

Academic Institutions and Nonprofits only

#48927

diversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.

George Church

Dec. 3, 2014

Academic Institutions and Nonprofits only

#48928

diversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.

George Church

Dec. 3, 2014

Academic Institutions and Nonprofits only

#48929

diversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.

George Church

Dec. 3, 2014

Academic Institutions and Nonprofits only

#48915

diversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.

George Church

Dec. 3, 2014

Academic Institutions and Nonprofits only

#48916

diversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.

George Church

Dec. 3, 2014

Academic Institutions and Nonprofits only

#48917

diversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.

George Church

Dec. 3, 2014

Academic Institutions and Nonprofits only

#48918

diversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.

George Church

Dec. 3, 2014

Academic Institutions and Nonprofits only

#48919

diversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.

George Church

Dec. 3, 2014

Academic Institutions and Nonprofits only

#48920

diversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.

George Church

Dec. 3, 2014

Academic Institutions and Nonprofits only

#48908

diversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.

George Church

Dec. 3, 2014

Academic Institutions and Nonprofits only

#48909

diversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.

George Church

Dec. 3, 2014

Academic Institutions and Nonprofits only